Alembic secures FDA approval for generic PradaxaDabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in certain instances. Nestlé Health Science to acquire Vowst from SeresNestlé Health Science will have full control over the further development, commercialization and manufacturing of Vowst in the U.S. and worldwide. Cranbury Pharmaceuticals receives FDA nod for generic Emflaza Deflazacort oral suspension is indicated to treat patients five years of age and older for Duchenne muscular dystrophy. Cipla receives FDA OK for generic Somatuline Depot Cipla’s lanreotide injection is indicated for the treatment of patients with acromegaly and gastroenteropancreatic neuroendocrine tumors. Lupin taps Abdelaziz Toumi as CEO of API CDMO subsidiary Toumi brings more than two decades of experience in the biotech, pharma and CDMO sectors, spanning Europe, North America and Asia. IQVIA report sizes up global oncology market Global spending on cancer medicine increased to $223 billion in 2023, $25 billion more than in 2022, and is projected to reach $409 billion by 2028. HRG’s five notable products from May 2024 HRG reviewed 13 products in the health category, 70 in the wellness sector and nine in the beauty aisle. Here are the ones to watch. Moderna receives FDA nod for RSV vaccine mRESVIA mRESVIA is Moderna’s second approved product and the only RSV vaccine available in single-dose pre-filled syringes. Scripta Insights names David Kershaw as chief technology officer As CTO, Kershaw will drive the company's technological strategies and lead the engineering and IT teams. Alembic obtains FDA nod for generic Firazyr Generic Firazyr is used for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older. First Previous 60 61 62 63 64 Next Last
